Acute interstitial nephritis associated with atazanavir, a new protease inhibitor
Acute interstitial nephritis associated with atazanavir, a new protease inhibitor
复制标题
DOI：
10.1053/j.ajkd.2004.07.017
复制
发表时间：
2004-11-01
影响因子：
13.2
通讯作者：
Perazella, MA
中科院分区：
文献类型：
--
作者：
Brewster, UC;Perazella, MA
Atazanavir是一种新的人类免疫缺陷病毒1蛋白酶抑制剂，具有良好的副作用，每日一次给药。我们报告的情况下，一个年轻的男子与人类免疫缺陷病毒感染谁发展急性肾功能衰竭治疗后，这种药物。肾活检显示急性间质性肾炎。这是阿扎那韦治疗急性间质性肾炎的第一份报告。
Atazanavir is a new human immunodeficiency virus 1 protease inhibitor that has a favorable side-effect profile and is available in once-daily dosing. We report the case of a young man with human immunodeficiency virus infection who developed acute renal failure after therapy with this drug. Renal biopsy showed acute interstitial nephritis. This is the first report of acute interstitial nephritis from atazanavir.